• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.23% Nasdaq Up1.31%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    8.87 Up 0.26(3.08%) 1:01PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 4,881   4,363   4,356   160,639  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,881   4,363   4,356   160,639  
    Operating Expenses
    Research Development34,062  88,428  36,082  44,895  
    Selling General and Administrative9,410  8,550  7,382  8,042  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (38,591) (92,615) (39,108) 107,702  
    Income from Continuing Operations
    Total Other Income/Expenses Net263  (40)(17)52  
    Earnings Before Interest And Taxes(38,328)(92,655)(39,125)107,754  
    Interest Expense100  647  1,034  4,538  
    Income Before Tax(38,428)(93,302)(40,159)103,216  
    Income Tax Expense -   -  183   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(38,428)(93,302)(40,342)103,216  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (38,428) (93,302) (40,342) 103,216  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (38,428) (93,302) (40,342) 103,216  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.